IL7R and graft versus host disease: Secondly, increased soluble IL-7R has been shown to bind free IL-7 and to inhibit IL-7 signaling (and therefore immune effector functions) in CD8+ T-cells from patients with infections [33]; inhibition of IL-7, via binding to soluble IL-7R, could potentially impact on GVHD development.